Unmasking the Hidden Threat: The Role of Left Ventricular Subendocardial Involvement in Autoimmune Rheumatic Disease
Clinical Cardiology · 2025
DOI: 10.1002/clc.70069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, 2025. Verfasst von Danni Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Rheumatic Diseases, Magnetic Resonance Imaging, Cine, Autoimmune Diseases, Ventricular Function, Left. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the CAMS Innovation Fund for Medical Sciences [2022-I2M-1-023] and the National High Level Hospital Clinical Research Funding [2022-….
Abstract (Originalsprache)
Background
Late gadolinium enhancement (LGE) has been found in patients with autoimmune rheumatic disease (ARD). However, the prognostic implications of some specific LGE patterns in ARD patients remain unclear.
Purpose
To investigate the prevalence and prognostic significance of left ventricular (LV) subendocardium‐involved LGE (LGEse) in a cohort of ARD patients. Materials and Methods This retrospective study evaluated 176 patients diagnosed with ARD with clinically suspected cardiac involvement between 2018 and 2023. LV LGEse was defined as LGE involving the LV subendocardium that did not correspond to a coronary vascular distribution. The endpoints included a composite of cardiac death, heart failure‐related admission, cardiogenic shock, and appropriate pacemaker or implantable cardioverter‐defibrillator therapy.
Results
Of the 176 consecutive patients, LV LGEse was observed in 22 patients (13%). During a median follow‐up of 776 days (interquartile range, 395–1405 days), 20 patients (11%) experienced a composite endpoint. Compared with those without LV LGEse, the LV LGEse group had a greater proportion of men (64% vs. 14%; p < 0.001), lower LV ejection fraction (50% vs. 60%; p = 0.001), greater LV end‐diastolic volume index (78 vs. 75; p = 0.043), and more adverse outcomes (32% vs. 8%; p = 0.005). In the univariable and multivariable Cox regression analyses, the LV LGEse showed independent prognostic value. In the sensitivity analyses, the prognostic difference in terms of LV subendocardial involvement remained.
Conclusion
In our cohort, LV subendocardial involvement, an underrecognized LGE pattern, was observed in 13% of all patients with autoimmune disease and indicated a worse prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.
Förderung
- This work was supported by the CAMS Innovation Fund for Medical Sciences [2022-I2M-1-023] and the National High Level Hospital Clinical Research Funding [2022-…
Zitieren
APA
Wu, D., Li, X., Guo, T., Feng, X., Li, X., Wang, Y., & Chen, W. (2025). Unmasking the Hidden Threat: The Role of Left Ventricular Subendocardial Involvement in Autoimmune Rheumatic Disease. Clinical Cardiology. https://doi.org/10.1002/clc.70069
Vancouver
Wu D, Li X, Guo T, Feng X, Li X, Wang Y, et al. Unmasking the Hidden Threat: The Role of Left Ventricular Subendocardial Involvement in Autoimmune Rheumatic Disease. Clinical Cardiology. 2025. doi:10.1002/clc.70069
BibTeX
@article{Wu2025,
author = {Wu, Danni and Li, Xiao and Guo, Tianchen and Feng, Xiaojin and Li, Xinhao and Wang, Yining and Chen, Wei},
title = {Unmasking the Hidden Threat: The Role of Left Ventricular Subendocardial Involvement in Autoimmune Rheumatic Disease},
journal = {Clinical Cardiology},
year = {2025},
doi = {10.1002/clc.70069}
}
EUVIMED